Comparison · documented facts only

Clinaxia or Pearl (Second Opinion 3D)?

We have read Pearl (Second Opinion 3D)'s own website and placed it side by side with what Clinaxia documents. Where Pearl (Second Opinion 3D) does not mention a feature, we write “not stated” — not “no”.

9

features Clinaxia documents that Pearl (Second Opinion 3D) does not state or lacks

3

features both document

2

features Pearl (Second Opinion 3D) documents that Clinaxia does not have yet

Clinaxia price

Solo NOK 1,715 · Clinic NOK 1,140 per clinician/mo, ex. VAT

Public price

Pearl (Second Opinion 3D) price

Not published on hellopearl.com (demo/contact)

Price not published

Where Clinaxia documents more

Features documented in Clinaxia that Pearl (Second Opinion 3D) either says no to, covers partially or does not mention on its website.

  • Voice → record draft

    Pearl (Second Opinion 3D): Not stated

  • HELFO tariff control vs. official source

    103 tariff codes verified figure by figure against the Directorate of Health circular and auto-cross-checked against Helfo open data

    Pearl (Second Opinion 3D): Not stated

  • Voice-driven perio charting

    Pearl (Second Opinion 3D): Not stated

  • Drug interaction check

    Pearl (Second Opinion 3D): Not stated

  • Referral / discharge / letters

    Pearl (Second Opinion 3D): Partial — “One-click” referral to a US board-certified radiologist inside the product – not Norwegian referral/discharge letters

  • Appointments and recall

    Pearl (Second Opinion 3D): Not stated

  • Patient communication

    Pearl (Second Opinion 3D): Not stated

  • AI shows its source (grounding)

    Grounding score on every AI block — try it on /evidens

    Pearl (Second Opinion 3D): Not stated

  • Flat price, all AI included

    Pearl (Second Opinion 3D): Not stated

What Pearl (Second Opinion 3D) documents that we do not have — yet

We do not hide this. Here is Clinaxia's status on each point.

  • Practice-system integration

    Pearl (Second Opinion 3D): Yes — Integrations with imaging/practice systems in the US market (Pearl Connect)

    Clinaxia: Partial — Opus export (clipboard/file); PMS integration in Enterprise tier

  • CE-marked (EU MDR)

    Pearl (Second Opinion 3D): Yes — States FDA clearance for both 2D and 3D; CE marking mentioned for Second Opinion (class not stated on the page)

    Clinaxia: Partial — Application pending — Clinaxia is decision support, not CE-marked diagnostics

Both document

Built for dentistryX-ray AI (decision support)CBCT / 3D viewer

The full table — point by point

FeatureClinaxiaPearl (Second Opinion 3D)
Target groupDental (complete clinical platform)Dental imaging AI: 2D X-ray (Second Opinion) and CBCT (Second Opinion 3D) – segmentation, pathology detection, documentation and radiologist referral. Not a practice system.
Price (from vendor website)Solo NOK 1,715 · Clinic NOK 1,140 per clinician/mo, ex. VATPublic priceNot published on hellopearl.com (demo/contact)Price not published
Trial7 days, no card (pilot 60)Not stated (book a demo)
LanguagesNO · SV · DA · ENEnglish (Norwegian not stated)
Built for dentistryYesYes
Voice → record draftYesNot stated
HELFO tariff control vs. official sourceYes103 tariff codes verified figure by figure against the Directorate of Health circular and auto-cross-checked against Helfo open dataNot stated
X-ray AI (decision support)YesYesSecond Opinion: FDA-cleared AI for pathology detection in 2D X-rays (vendor claim)
Voice-driven perio chartingYesNot stated
CBCT / 3D viewerYesYesSecond Opinion 3D: color-coded 3D segmentation (nerve canal, sinus, airway, teeth), pathology detection (incl. periapical radiolucency, impactions, sinus radiopacities), 2D images for insurance claims
Drug interaction checkYesNot stated
Referral / discharge / lettersYesPartial“One-click” referral to a US board-certified radiologist inside the product – not Norwegian referral/discharge letters
Appointments and recallYesNot stated
Patient communicationYesNot stated
AI shows its source (grounding)YesGrounding score on every AI block — try it on /evidensNot stated
Practice-system integrationPartialOpus export (clipboard/file); PMS integration in Enterprise tierYesIntegrations with imaging/practice systems in the US market (Pearl Connect)
Flat price, all AI includedYesNot stated
CE-marked (EU MDR)PartialApplication pending — Clinaxia is decision support, not CE-marked diagnosticsYesStates FDA clearance for both 2D and 3D; CE marking mentioned for Second Opinion (class not stated on the page)
ISO 27001NoNot certified yetNot stated
Data locationEU/EEANot stated on the product page (US company)

Documented on the website · Pearl (Second Opinion 3D)

  • •First dental AI company FDA-cleared for both 2D and 3D imaging (May 2025, own press release)
  • •Sells imaging AI – not records, Norwegian reimbursement, prescriptions or patient communication
  • •Clinaxia Vision covers the corresponding CBCT features (segmentation, 3D, pathology screening with clinician approval, 2D documentation, sharing) inside the same platform as records and reimbursement

Documented at Clinaxia

  • The only one of the four with X-ray AI, voice perio and CBCT in one platform
  • HELFO tariff control against the official source — not just code suggestions
  • Open pricing on the website, every AI module included
  • AI shows its source or says “don't know” (grounding score)

Measured in Clinaxia — not promised

See how we measure →

103

HELFO tariffs verified against the Directorate of Health

100 %

match with Helfo open data (2026-11-07)

4.3

min measured active time per record (n=17)

599 · 556

test runs · regression suites

We only show what the vendor states itself. Where a website does not mention a feature, we write “not stated” — not “no”. Comparative advertising: the information is objective, verifiable and linked to its source. Report errors to hei@clinaxia.com — we correct within 48 hours.

Test the difference yourself — 7 days free

No card. Every AI module included from day one.

Start free

Only necessary cookies – no tracking. Privacy policy